Schedule 13G ownership disclosure

DBV TECHNOLOGIES SA

Ordinary Shares, nominal value Euro 0.10 per share · CUSIP: 23306J309

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Invus Public Equities, L.P.

    Shares: 13,038,825.00 · Class: 5.6%

  • Invus Public Equities Advisors, LLC

    Shares: 13,038,825.00 · Class: 5.6%

  • Invus Global Management, LLC

    Shares: 13,038,825.00 · Class: 5.6%

  • Siren, L.L.C.

    Shares: 13,038,825.00 · Class: 5.6%

  • Avicenna Life Sci Master Fund LP

    Shares: 1,312,135.00 · Class: 0.6%

  • Avicenna Life Sci Master GP LLC

    Shares: 1,312,135.00 · Class: 0.6%

  • Ulys, L.L.C.

    Shares: 1,312,135.00 · Class: 0.6%

  • Raymond Debbane

    Shares: 14,350,960.00 · Class: 6.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002005369-26-000008
Form type
SCHEDULE 13G/A
Filer
DBV Technologies S.A.
CIK
CIK 1613780
Filed
Feb 13, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub